Mail: Microbiology Research Building, 1st floor mail room, MMC 2821, 689 SE 23rd Ave, Minneapolis, MN 55455
Dr. Rajasingham is an Infectious Diseases physician and physician-scientist at the University of Minnesota. Her primary research interest is to maximize the public health impact of screening HIV-infected persons for opportunistic infections in order to decrease HIV/AIDS-related mortality. She is particularly interested in the evaluation of cost-effective diagnostics and treatment algorithms to care of persons with advanced HIV disease. Dr. Rajasingham is the co-PI of a phase II randomized clinical trial in Uganda evaluating the safety of high dose AmBisome to prevent cryptococcal meningitis in persons with advanced HIV disease, and PI for an R01 cluster-randomized trial evaluating point-of-care diagnostics in persons with advanced HIV disease, funded by NIAID.
Dr. Rajasingham is a physician-scientist trained in the clinical practice of infectious diseases. Her research interests span evaluation and cost-effectiveness of point-of-care diagnostics in persons with advanced HIV disease, cryptococcal screening and prevention, and management of cryptococcal meningitis.
- Evaluation of CRAG Screening with Enhanced Antifungal Therapy for Asymptomatic CRAG-Positive Persons (K23AI138851)
- An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV Disease (R01AI162181)
- Global Health